ArticleCancer medicine2020
The clinical application value of mixed-reality-assisted surgical navigation for laparoscopic nephrectomy.
Article in Cancer medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 5 syntheses or guidelines pooled it, 38 citations in OpenAlex.
- Augmented reality for basic skills training in laparoscopic surgery: a systematic review and meta-analysis.Surgical endoscopy · 2025Pooled it
- Augmented Reality Implementation in Minimally Invasive Surgery for Future Application in Pulmonary Surgery: A Systematic Review.Surgical innovation · 2024Pooled it
- More than meets the eye: Augmented reality in surgical oncology.Journal of surgical oncology · 2024Pooled it
- Visual extended reality tools in image-guided surgery in urology: a systematic review.European journal of nuclear medicine and molecular imaging · 2024Pooled it
- Utility of optical see-through head mounted displays in augmented reality-assisted surgery: A systematic review.Medical image analysis · 2022Pooled it
- The clinical application value of mixed reality guidance in robot-assisted laparoscopic radical nephrectomy for renal cancer.Journal of robotic surgery · 2026Article
- Exploring the advantages of mixed reality technology in Robot-assisted laparoscopic partial adrenalectomy.World journal of surgical oncology · 2026Article
- High-speed optical tracking and augmented reality platform for image-guided interventions.Journal of medical imaging (Bellingham, Wash.) · 2026Article
- The application of mixed reality navigation system in robot-assisted radical prostatectomy for high-risk prostate cancer: a propensity score‑matched cohort study.Prostate cancer and prostatic diseases · 2026Article
- Intraoperative use of mixed reality (MR) in humans across surgical disciplines: a major review.3D printing in medicine · 2025Article
- Article
- Bridging traditional gaps in medical training with mixed reality: insights from bronchoscopy education-a narrative review.Journal of thoracic disease · 2025Review
- The Depth Estimation and Visualization of Dermatological Lesions: Development and Usability Study.JMIR dermatology · 2024Article
- Current Application of Navigation Systems in Robotic-Assisted and Laparoscopic Partial Nephrectomy: Focus on the Improvement of Surgical Performance and Outcomes.Annals of surgical oncology · 2024Review
- The clinical application value of mixed reality in robotic laparoscopic partial nephrectomy.Frontiers in oncology · 2024Article
- Mixed reality navigation training system for liver surgery based on a high-definition human cross-sectional anatomy data set.Cancer medicine · 2023Article
- Mixed Reality in Modern Surgical and Interventional Practice: Narrative Review of the Literature.JMIR serious games · 2023Review
- Effect of augmented reality navigation technology on perioperative safety in partial nephrectomies: A meta-analysis and systematic review.Frontiers in surgery · 2023Review
- Application value of mixed reality in hepatectomy for hepatocellular carcinoma.World journal of gastrointestinal surgery · 2022Article
- Applications of Mixed Reality Technology in Orthopedics Surgery: A Pilot Study.Frontiers in bioengineering and biotechnology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeLaparoscopic nephrectomy (LN) has become the preferred method for renal cell carcinoma (RCC). Adequate preoperative assessment or intraoperative navigation is key to the successful implementation of LN. The aim of this study was to evaluate the clinical application value of mixed-reality-assisted surgical navigation (MRASN) in LN. PATIENTS AND
methodsA total of 100 patients with stage T1N0M0 renal tumors who underwent laparoscopic partial nephrectomy (LPN) or laparoscopic radical nephrectomy (LRN) were prospectively enrolled and divided into a mixed-reality-assisted laparoscopic nephrectomy (MRALN) group (n = 50) and a non-mixed-reality-assisted laparoscopic nephrectomy (non-MRALN) group (n = 50). All patients underwent renal contrast-enhanced CT scans. The CT DICOM data of all patients in the MRALN group were imported into the mixed-reality (MR) postprocessing workstation and underwent holographic three-dimensional visualization (V3D) modeling and MR displayed, respectively. We adopted the Likert scale to evaluate the clinical application value of MRASN. The consistency of evaluators was assessed using the Cohen kappa coefficient (k).
resultsNo significant differences in patient demographic indicators between the MRALN group and the non-MRALN group (P > .05). The subjective score of MRASN clinical application value in operative plan formulation, intraoperative navigation, remote consultation, teaching guidance, and doctor-patient communication were higher in the MRASN group than in the non-MRASN group (all P < .001). There were significantly more patients for whom LPN was successfully implemented in the MRALN group than in the non-MRALN group (82% vs 46%, P < .001). The MRALN group had a shorter operative time (OT) and warm ischemia time (WIT) and less estimated blood loss (EBL) than the non-MRALN group (all P < .001).
conclusionMRASN is helpful for operative plan formulation, intraoperative navigation, remote consultation, teaching guidance, and doctor-patient communication. MRALN may effectively improve the successful implementation rate of LPN and reduce the OT, WIT, and EBL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.